Fujian Aonong Biological Technology Group Incorporation Limited(603363) may 20 announcement: the company’s controlling shareholder aonong investment and actual controller Wu Youlin issued a notice on reducing aonong convertible bonds. On May 18, 2022, aonong investment reduced 3622920 aonong convertible bonds held by it through block trading, and Wu Youlin reduced 1306600 aonong convertible bonds held by it through block trading, with a total reduction of 4929520 aonong convertible bonds, accounting for 492952% of the total issuance of aonong convertible bonds. The capital obtained from this reduction is mainly used to promote the steady development of the company. After this reduction, aonong investment no longer holds aonong convertible bonds, and Wu Youlin holds 200 aonong convertible bonds, accounting for 0.002% of the total issuance of aonong convertible bonds.
Meanwhile, Huaneng Guicheng Trust Co., Ltd. (on behalf of “Huaneng trust · YONGYING Anhua collective fund trust plan”) bought 4929520 aonong convertible bonds through block trading on May 18, 2022, accounting for 492952% of the total issuance of aonong convertible bonds.
It is reported that Fujian Aonong Biological Technology Group Incorporation Limited(603363) on March 10, 2021 publicly issued 10 million convertible corporate bonds with a face value of 100 yuan each, a total issuance amount of 1 billion yuan and a term of 6 years. The company’s 1 billion yuan convertible corporate bonds were listed and traded on the Shanghai Stock Exchange from April 2, 2021. The bonds are referred to as “aonong convertible bonds” for short, and the bond code is 113620 Aonong investment, the controlling shareholder of the company, subscribed 3622920 aonong convertible bonds through preferential placement, and Wu Youlin, the actual controller of the company, subscribed 1306800 aonong convertible bonds through preferential placement, holding a total of 4929720 aonong convertible bonds, accounting for 492972% of the total issuance of aonong convertible bonds.
